Solid Biosciences (NASDAQ: SLDB)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Solid Biosciences (NASDAQ: SLDB) through any online brokerage.
The latest price target for Solid Biosciences (NASDAQ: SLDB) was reported by Piper Sandler on Thursday, May 19, 2022. The analyst firm set a price target for 2.00 expecting SLDB to rise to within 12 months (a possible 247.22% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Solid Biosciences (NASDAQ: SLDB) is $0.576 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Solid Biosciences.
Solid Biosciences’s Q2 earnings are confirmed for Wednesday, September 14, 2022.
There is no upcoming split for Solid Biosciences.
Solid Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.